Revisiting an unsolved problem – impact of SLICC criteria on the risk of metabolic syndrome

Abstract

Get full access to this article

View all access options for this article.

References

Demir

Artim-Esen

Sahinkaya

. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients. Lupus 2016; 25: 177–184.

Lakka

Laaksonen

Lakka

. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709–2716.

Danesh

Wheeler

Hirschfield

. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387–1397.

Chung

Avalos

Oeser

. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 2007; 66: 208–214.

Sinicato

Postal

Peres

. Obesity and cytokines in childhood-onset systemic lupus erythematosus. J Immunol Res 2014; 2014: 162047–162047.

Pereira

de Carvalho

Bonfa

. Metabolic syndrome in rheumatological diseases. Autoimmun Rev 2009; 8: 415–419.

Chung

Long

Solus

. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 2009; 18: 799–806.

Azevedo

Gadelha

Vilar

. Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA. Ann Rheum Dis 2007 Nov; 66: 1542–1542.

Parker

Bruce

. SLE and metabolic syndrome. Lupus 2013; 22: 1259–1266.

10.

Parker

Ahmad

Shelmerdine

. An analysis of the metabolic syndrome phenotype in systemic lupus erythematosus. Lupus 2011; 20: 1459–1465.